Investigation ofNRXN1deletions: Clinical and molecular characterization
- 12 March 2013
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 161 (4), 717-731
- https://doi.org/10.1002/ajmg.a.35780
Abstract
Deletions at 2p16.3 involving exons of NRXN1 are associated with susceptibility for autism and schizophrenia, and similar deletions have been identified in individuals with developmental delay and dysmorphic features. We have identified 34 probands with exonic NRXN1 deletions following referral for clinical microarray‐based comparative genomic hybridization. To more firmly establish the full phenotypic spectrum associated with exonic NRXN1 deletions, we report the clinical features of 27 individuals with NRXN1 deletions, who represent 23 of these 34 families. The frequency of exonic NRXN1 deletions among our postnatally diagnosed patients (0.11%) is significantly higher than the frequency among reported controls (0.02%; P = 6.08 × 10−7), supporting a role for these deletions in the development of abnormal phenotypes. Generally, most individuals with NRXN1 exonic deletions have developmental delay (particularly speech), abnormal behaviors, and mild dysmorphic features. In our cohort, autism spectrum disorders were diagnosed in 43% (10/23), and 16% (4/25) had epilepsy. The presence of NRXN1 deletions in normal parents and siblings suggests reduced penetrance and/or variable expressivity, which may be influenced by genetic, environmental, and/or stochastic factors. The pathogenicity of these deletions may also be affected by the location of the deletion within the gene. Counseling should appropriately represent this spectrum of possibilities when discussing recurrence risks or expectations for a child found to have a deletion in NRXN1.This publication has 63 references indexed in Scilit:
- Haploinsufficiency ofSOX5at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic featuresHuman Mutation, 2012
- SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of Neurexin-1Cell, 2011
- Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophreniaHuman Genetics, 2011
- Detection of clinically relevant exonic copy-number changes by array CGHHuman Mutation, 2010
- Rare NRXN1 promoter variants in patients with schizophreniaNeuroscience Letters, 2010
- CNTNAP2 and NRXN1 Are Mutated in Autosomal-Recessive Pitt-Hopkins-like Mental Retardation and Determine the Level of a Common Synaptic Protein in DrosophilaAmerican Journal of Human Genetics, 2009
- Recurrent Rearrangements in Synaptic and Neurodevelopmental Genes and Shared Biologic Pathways in Schizophrenia, Autism, and Mental RetardationArchives of General Psychiatry, 2009
- Recurrent CNVs Disrupt Three Candidate Genes in Schizophrenia PatientsAmerican Journal of Human Genetics, 2008
- Disruption of Neurexin 1 Associated with Autism Spectrum DisorderAmerican Journal of Human Genetics, 2008
- Autism, asthma, inflammation, and the hygiene hypothesisMedical Hypotheses, 2007